Oral Resveratrol Therapy Inhibits Cancer-Induced Skeletal Muscle and Cardiac Atrophy In Vivo
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral Resveratrol Therapy Inhibits Cancer-Induced Skeletal Muscle and Cardiac Atrophy In Vivo
Authors
Keywords
-
Journal
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
Volume 63, Issue 5, Pages 749-762
Publisher
Informa UK Limited
Online
2011-06-11
DOI
10.1080/01635581.2011.563032
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse
- (2010) Paola Aulino et al. BMC CANCER
- Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival
- (2010) Xiaolan Zhou et al. CELL
- Cancer cachexia
- (2010) Michael J Tisdale CURRENT OPINION IN GASTROENTEROLOGY
- Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia
- (2010) James A. Carson et al. EXERCISE AND SPORT SCIENCES REVIEWS
- Are tumoral factors responsible for host tissue wasting in cancer cachexia?
- (2010) Michael J Tisdale Future Oncology
- Muscle ring finger 1 mediates cardiac atrophy in vivo
- (2009) Monte S. Willis et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Regulation and Function of NF-κB Transcription Factors in the Immune System
- (2009) Sivakumar Vallabhapurapu et al. Annual Review of Immunology
- Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma
- (2009) Anupam Bishayee et al. CANCER TREATMENT REVIEWS
- Resveratrol and Neurodegenerative Diseases: Activation of SIRT1 as the Potential Pathway towards Neuroprotection
- (2009) Merce Pallas et al. CURRENT NEUROVASCULAR RESEARCH
- Safety studies conducted on high-purity trans-resveratrol in experimental animals
- (2009) Lonnie D. Williams et al. FOOD AND CHEMICAL TOXICOLOGY
- During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation
- (2009) Shenhav Cohen et al. JOURNAL OF CELL BIOLOGY
- Mechanisms of Cancer Cachexia
- (2009) Michael J. Tisdale PHYSIOLOGICAL REVIEWS
- Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice
- (2009) Philipp Weyermann et al. PLoS One
- The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene
- (2008) David S. Waddell et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The IκB kinases IKKα and IKKβ are necessary and sufficient for skeletal muscle atrophy
- (2008) Darin Van Gammeren et al. FASEB JOURNAL
- Nuclear factor-kappa B signaling in skeletal muscle atrophy
- (2008) Hong Li et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Metabolomic analysis of cancer cachexia reveals distinct lipid and glucose alterations
- (2008) Thomas M. O’Connell et al. Metabolomics
- Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice
- (2008) Emanuele Berardi et al. NEUROLOGICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now